TrianglePUBLICATIONS · 19017755
Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumors.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Endocrinol Metab
- Publication date
- 2009 Feb
- First author
- Jimenez C
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Jimenez C
- type
- Author
- name
- Cabanillas ME
- type
- Author
- name
- Santarpia L
- type
- Author
- name
- Jonasch E
- type
- Author
- name
- Kyle KL
- type
- Author
- name
- Lano EA
- type
- Author
- name
- Matin SF
- type
- Author
- name
- Nunez RF
- type
- Author
- name
- Perrier ND
- type
- Author
- name
- Phan A
- type
- Author
- name
- Rich TA
- type
- Author
- name
- Shah B
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Jimenez C
- type
- Author
- name
- Cabanillas ME
- type
- Author
- name
- Santarpia L
- type
- Author
- name
- Jonasch E
- type
- Author
- name
- Kyle KL
- type
- Author
- name
- Lano EA
- type
- Author
- name
- Matin SF
- type
- Author
- name
- Nunez RF
- type
- Author
- name
- Perrier ND
- type
- Author
- name
- Phan A
- type
- Author
- name
- Rich TA
- type
- Author
- name
- Shah B
- type
- Author
- bibliography ids
- nci-bib-e5d7ef03ac7b13485a5ba19d
- book metadata
- content sha256
- ab14461913a51184c66eed2467602eed044ba6ec73d72f2776f497e6027b393a
- document type
- citation
- dois
- 10.1210/jc.2008-1972
- electronic publication date
- display
- 2008 Nov 18
- precision
- day
- year
- 2008
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:19017755
- immutable id
- pubmed:19017755@ab14461913a51184c66eed2467602eed044ba6ec73d72f2776f497e6027b393a
- journal
- abbreviation
- J Clin Endocrinol Metab
- issn electronic
- Source null
- issn print
- 0021-972X
- issue
- 2
- name
- The Journal of clinical endocrinology and metabolism
- nlm unique id
- 0375362
- pages
- 386-91
- volume
- 94
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 19017755
- provenance
- batch id
- 27a383f06e5fc3d04fad
- provider
- NCBI PubMed ESummary
- record sha256
- 78459e6f6e7ff39f1347d05ce7a68a280901e68654c5a9bc1523e42778918d9d
- response sha256
- 51f0f2a142dbd9b135e872b049b116f51941299445a5416feae10f12fac8d978
- retrieved at
- 2026-09-09T23:46:24.265787+00:00
- publication date
- display
- 2009 Feb
- precision
- month
- year
- 2009
- publication types
- Case Reports
- Evaluation Study
- Journal Article
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumors.
Preserved source evidence · Not medical advice